LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Fortis Capital Management LLC's Holding History (CIK: 0001802167)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 12,092 Value ($000) $7 Avg Close — Range —
Q4 2024
Shares 12,092 Value ($000) $8 Avg Close — Range —
Q3 2024
Shares 12,092 Value ($000) $17 Avg Close — Range —
Q2 2024
Shares 12,092 Value ($000) $18 Avg Close — Range —
Q1 2024
Shares 12,092 Value ($000) $27 Avg Close — Range —